| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
|
Am J Respir Crit Care Med
|
2009
|
3.57
|
|
2
|
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
|
Am J Respir Crit Care Med
|
2006
|
3.20
|
|
3
|
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
|
Am J Respir Crit Care Med
|
2015
|
1.86
|
|
4
|
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.
|
Antimicrob Agents Chemother
|
2007
|
1.72
|
|
5
|
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.
|
AIDS
|
2004
|
1.65
|
|
6
|
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis.
|
J Clin Microbiol
|
2007
|
1.64
|
|
7
|
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
|
J Infect Dis
|
2012
|
1.53
|
|
8
|
Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.
|
Am J Respir Crit Care Med
|
2008
|
1.47
|
|
9
|
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.
|
Antimicrob Agents Chemother
|
2010
|
1.45
|
|
10
|
Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
|
J Infect Dis
|
2003
|
1.44
|
|
11
|
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
|
J Infect Dis
|
2004
|
1.39
|
|
12
|
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.
|
PLoS One
|
2011
|
1.38
|
|
13
|
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
|
Am J Respir Crit Care Med
|
2011
|
1.37
|
|
14
|
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.
|
Clin Diagn Lab Immunol
|
2002
|
1.35
|
|
15
|
Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.
|
J Virol
|
2002
|
1.27
|
|
16
|
Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.
|
Antimicrob Agents Chemother
|
2009
|
1.24
|
|
17
|
Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.
|
PLoS One
|
2013
|
1.24
|
|
18
|
Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.
|
PLoS One
|
2010
|
1.15
|
|
19
|
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.
|
J Clin Microbiol
|
2010
|
1.11
|
|
20
|
Guided sputum sample collection and culture contamination rates in the diagnosis of pulmonary TB.
|
J Bras Pneumol
|
2009
|
1.03
|
|
21
|
Mechanisms of apoptosis of T-cells in human tuberculosis.
|
J Clin Immunol
|
2005
|
0.97
|
|
22
|
Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects.
|
Clin Diagn Lab Immunol
|
2005
|
0.97
|
|
23
|
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.
|
J Natl Cancer Inst
|
2002
|
0.94
|
|
24
|
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
|
J Clin Oncol
|
2009
|
0.92
|
|
25
|
A metabolic biosignature of early response to anti-tuberculosis treatment.
|
BMC Infect Dis
|
2014
|
0.92
|
|
26
|
The association between symptoms and microbiologically defined response to tuberculosis treatment.
|
Ann Am Thorac Soc
|
2013
|
0.92
|
|
27
|
Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
|
Chest
|
2014
|
0.89
|
|
28
|
Weight gain and response to treatment for multidrug-resistant tuberculosis.
|
Am J Trop Med Hyg
|
2013
|
0.89
|
|
29
|
Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil.
|
PLoS One
|
2013
|
0.87
|
|
30
|
Capacity building for the clinical investigation of AIDS malignancy in East Africa.
|
Cancer Detect Prev
|
2005
|
0.87
|
|
31
|
Recent advances in the diagnosis and management of tuberculosis.
|
Curr Opin Pulm Med
|
2005
|
0.86
|
|
32
|
Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model.
|
BMC Infect Dis
|
2014
|
0.86
|
|
33
|
Evaluation of oral antiseptic rinsing before sputum collection to reduce contamination of mycobacterial cultures.
|
J Clin Microbiol
|
2011
|
0.85
|
|
34
|
Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapy.
|
J Clin Microbiol
|
2011
|
0.85
|
|
35
|
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment.
|
PLoS One
|
2013
|
0.85
|
|
36
|
A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.
|
Antimicrob Agents Chemother
|
2011
|
0.85
|
|
37
|
Time until relapse in tuberculosis treatment trials: implication for phase 3 trial design.
|
Am J Respir Crit Care Med
|
2012
|
0.85
|
|
38
|
Household members and health care workers as supervisors of tuberculosis treatment.
|
Rev Saude Publica
|
2010
|
0.84
|
|
39
|
Osteomyelitis in diabetic foot ulcers. Prompt diagnosis can avert amputation.
|
Postgrad Med
|
2005
|
0.84
|
|
40
|
Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda.
|
BMC Pulm Med
|
2002
|
0.81
|
|
41
|
Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.
|
Tuberculosis (Edinb)
|
2012
|
0.79
|
|
42
|
Digital clubbing in tuberculosis--relationship to HIV infection, extent of disease and hypoalbuminemia.
|
BMC Infect Dis
|
2006
|
0.76
|
|
43
|
Effect of improving the quality of radiographic interpretation on the ability to predict pulmonary tuberculosis relapse.
|
Acad Radiol
|
2009
|
0.75
|
|
44
|
Whither Mycobacterium vaccae--encore.
|
Lancet
|
2002
|
0.75
|
|
45
|
Saline nebulization before gastric lavage in the diagnosis of pulmonary tuberculosis in children and adolescents.
|
J Trop Pediatr
|
2010
|
0.75
|
|
46
|
Rifampicin-containing regimens for the treatment of latent tuberculosis infection also prevented diarrheal illnesses in HIV-infected Ugandan adults.
|
AIDS
|
2004
|
0.75
|
|
47
|
Prosthetic joint infection: when to suspect it, how to manage it.
|
Geriatrics
|
2007
|
0.75
|